Company profile for Elevation Oncology

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Elevation Oncology advocates for genomic testing for all, because every patient deserves to know what is uniquely driving the growth of their tumor. We develop purpose-built precision medicines matched to these unique genomic drivers, because it’s not enough to just know why a tumor is growing, there must also be drugs available to stop it. We call for collaboration within our research and industry communities, because the t...
Elevation Oncology advocates for genomic testing for all, because every patient deserves to know what is uniquely driving the growth of their tumor. We develop purpose-built precision medicines matched to these unique genomic drivers, because it’s not enough to just know why a tumor is growing, there must also be drugs available to stop it. We call for collaboration within our research and industry communities, because the treatment of cancer is complex. Only together can our community develop enough unique precision therapeutics to ensure that every genomic test result is actionable and leads to improved outcomes for our patients.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
888 7th Ave, 12th Floor New York, NY 10106
Telephone
Telephone
+1 (716) 371-1125
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/elevation-oncology-reports-first-quarter-2025-financial-results-and-provides-business-updates-302456360.html

PR NEWSWIRE
15 May 2025

https://www.prnewswire.com/news-releases/elevation-oncology-presents-preclinical-proof-of-concept-data-for-eo-1022-at-the-american-association-for-cancer-research-aacr-annual-meeting-2025-302437000.html

PR NEWSWIRE
25 Apr 2025

https://www.fiercebiotech.com/biotech/elevation-latest-biotech-face-activist-investor-demands-wind-down

FIERCE BIOTECH
17 Apr 2025

https://www.prnewswire.com/news-releases/elevation-oncology-to-present-preclinical-data-for-eo-1022-at-the-american-association-for-cancer-research-aacr-annual-meeting-2025-302407842.html

PR NEWSWIRE
25 Mar 2025

https://www.prnewswire.com/news-releases/elevation-oncology-to-discontinue-development-of-eo-3021-advancing-eo-1022-while-evaluating-strategic-options-302406229.html

PRNEWSWIRE
21 Mar 2025

https://www.prnewswire.com/news-releases/elevation-oncology-to-discontinue-development-of-eo-3021-advancing-eo-1022-while-evaluating-strategic-options-302406229.html

PR NEWSWIRE
20 Mar 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty